Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation: Heart Failure

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.109.931451PMID 21075869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.

  2010cited by this paper
• Human parvovirus B19-associated myocarditis.

  2010cited by this paper
• Immunomodulation and matrix metalloproteinases in viral myocarditis.

  2010cited by this paper
• Ernst Schering Research Foundation Workshop

  2010cited by this paper
• The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion.

  2009cited by this paper
• Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence.

  2009cited by this paper
• Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

  2009cited by this paper
• Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure

  2009cited by this paper
• Is echocardiographic evaluation of diastolic function useful in determining clinical care? Doppler echocardiography yields dubious estimates of left ventricular diastolic pressures.

  2009cited by this paper
• Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover

  2009cited by this paper
• Titin-based mechanical signalling in normal and failing myocardium.

  2009cited by this paper
• Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.

  2009cited by this paper
• Heart Failure with Normal Ejection Fraction

  2009cited by this paper
• Heart Failure with Normal Ejection Fraction

  2009cited by this paper
• Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

  2009cited by this paper
• Cardiac Fibroblast: The Renaissance Cell

  2009cited by this paper
• Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure.

  2009cited by this paper
• Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.

  2008cited by this paper
• Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension

  2008cited by this paper
• Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction

  2008cited by this paper
• Titin Isoforms, Extracellular Matrix, and Global Chamber Remodeling in Experimental Dilated Cardiomyopathy: Functional Implications and Mechanistic Insight

  2008cited by this paper
• Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic Cardiomyopathy

  2007cited by this paper
• Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction: A Comparative Doppler-Conductance Catheterization Study

  2007cited by this paper
• How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

  2007cited by this paper
• Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction

  2007cited by this paper
• Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota

  2007cited by this paper
• Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy

  2007cited by this paper
• Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

  2007cited by this paper
• Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.

  2007cited by this paper
• Human T cells stimulate fibroblast‐mediated degradation of extracellular matrix in vitro

  2007cited by this paper
• Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

  2007cited by this paper
• Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure.

  2007cited by this paper
• Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

  2006cited by this paper
• Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis

  2006cited by this paper
• Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.

  2006cited by this paper
• Inflammatory cardiomyopathy: there is a specific matrix destruction in the course of the disease.

  2006cited by this paper
• Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction

  2006cited by this paper
• Outcome of heart failure with preserved ejection fraction in a population-based study.

  2006cited by this paper
• Trends in prevalence and outcome of heart failure with preserved ejection fraction.

  2006cited by this paper
• Heart failure with a normal ejection fraction

  2005cited by this paper
• Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

  2005cited by this paper
• Cardiomyocyte Stiffness in Diastolic Heart Failure

  2005cited by this paper
• Ventricular Diastolic Dysfunction High Prevalence of Cardiac Parvovirus B 19 Infection in Patients With Isolated Left

  2005cited by this paper
• Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart

  2005cited by this paper
• Widespread Myocardial Inflammation and Infarct-Related Artery Patency

  2004cited by this paper
• Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin: Relation to Myocardial Fibrosis

  2004cited by this paper
• Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

  2004cited by this paper
• The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor- (cid:1) 1*

  2003cited by this paper
• The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1.

  2003cited by this paper
• The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1*

  2003cited by this paper
• The role of inflammation in the pathogenesis of heart failure

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.

  2002cited by this paper
• Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio.

  1999cited by this paper
• Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.

  1997cited by this paper
• Endometriosis: pathophysiology, diagnosis, and treatment.

  1989cited by this paper
• Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass.

  1987cited by this paper

• Gut Microbiota and Short-Chain Fatty Acids in Cardiometabolic HFpEF: Mechanistic Pathways and Nutritional Therapeutic Perspectives

  2026cites this paper
• Neutrophil arrest in myocardial capillaries drives hypoxia and impairs diastolic function in a mouse model of heart failure with preserved ejection fraction

  2026cites this paper
• The alarmin tandem: unraveling the complex effect of S100A8/A9 – from atherosclerosis to cardiac arrhythmias

  2025cites this paper
• Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity

  2025cites this paper
• The brain–heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation

  2025cites this paper
• Macrophage metabolism in inflammatory heart disease: new insights and therapeutic implications

  2025cites this paper
• Vascular Cell Adhesion Molecule 1 in Heart Failure-Stuck on You.

  2025cites this paper
• The association of life’s essential 8 with prevalence of chronic respiratory diseases in adults: insights from NHANES 2007–2018

  2025cites this paper
• SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established

  2025cites this paper
• The Mechanisms Associated with Inflammation and Coronary Microvascular Dysfunction in The Heart Failure with Preserved Ejection Fraction.

  2025cites this paper
• Multifactorial mechanisms of obesity-related HFpEF: the central role of epicardial adipose tissue and therapeutic perspectives

  2025cites this paper
• Cardiovascular rehabilitation in rheumatoid arthritis: evidence and future directions

  2025cites this paper
• Systems biology approach uncovers candidates for kidney-heart interorgan crosstalk after myocardial infarction

  2025cites this paper
• Focusing on microvascular function in heart failure with preserved ejection fraction

  2025cites this paper
• Evolutionary History of the Comorbidity-Driven Coronary Microvascular Endothelial Inflammation Hypothesis and Its Metamorphosis to the Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction.

  2025cites this paper
• Risk Factors of Subclinical Left Ventricular Systolic Dysfunction in Older Adults with Type 2 Diabetes and Preserved LVEF

  2025cites this paper
• The left atrium in heart failure with preserved ejection fraction: What we know and what we do not know

  2025cites this paper
• The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction

  2025cites this paper
• Mechanistic Links Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction in a Mouse Model

  2025cites this paper
• Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential

  2025cites this paper
• Efficacy and safety of creatine phosphate sodium in the treatment of viral myocarditis: A systematic review and meta-analysis

  2025cites this paper
• TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model

  2025cites this paper
• Serum soluble transferrin receptor (sTfR) in HFpEF: associations with cardiac function and exercise tolerance

  2025cites this paper
• Myeloid cell recruitment propels right ventricular dysfunction in HFpEF via sterile inflammation

  2025cites this paper
• Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage

  2025cites this paper
• Cardiac fibroblasts in myocardial injury and heart failure.

  2025cites this paper
• Echocardiographic predictors of futile recanalization in acute ischemic stroke

  2025cites this paper
• Modulation of Macrophage Polarization by Traditional Chinese Medicine in HFpEF: A Review of Mechanisms and Therapeutic Potentials

  2025cites this paper
• Loss of Hepatic Angiotensinogen Attenuates Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction

  2025cites this paper
• Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs

  2025cites this paper
• Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges

  2025cites this paper
• The Cardiohepatic Axis in Metabolic Disease

  2025cites this paper
• The Role of Inflammation in the Pathophysiology of Heart Failure

  2025cites this paper
• Periodontitis Accelerates Progression of Heart Failure With Preserved Ejection Fraction in Mice

  2025cites this paper
• Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential

  2025cites this paper
• CCR2+ MONOCYTE-DERIVED MACROPHAGES DRIVE CARDIAC HYPERTROPHY IN EARLY HFPEF.

  2025cites this paper
• Cardiometabolic Phenotype in HFpEF: Insights from Murine Models

  2025cites this paper
• Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes

  2025cites this paper
• Insights into Pulmonary Arterial Hypertension in Connective Tissue Diseases

  2025cites this paper
• A critical role for IL-21/IL-21 receptor signaling in isoproterenol-induced cardiac remodeling

  2025cites this paper
• The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF

  2025cites this paper
• Coronary Microvascular Dysfunction: Insights on Prognosis and Future Perspectives

  2025cites this paper
• NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity

  2025cites this paper
• The relationship between tissue inhibitor of metalloproteinases-1 and KCNJ5 mutation in aldosterone-producing adenoma patients

  2024cites this paper
• Novel Therapeutic Strategies Targeting Fibroblasts to Improve Heart Disease

  2024cites this paper
• Editorial: Current proceedings in magnetocardiology—past, present, future

  2024cites this paper
• Серцева недостатність зі збереженою фракцією викиду та метаболічний синдром. Основні фактори розвитку, роль епікардіального жиру

  2024cites this paper
• Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort

  2024cites this paper
• Beyond Encapsulation: Exploring Macrophage-Fibroblast Cross Talk in Implant-Induced Fibrosis

  2024cites this paper
• Enhanced Adhesion Molecules are Early Inflammatory Driver in Symptomatic Patients with Preserved Ejection Fraction Prior to Diastolic Dysfunction

  2024cites this paper
• The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis

  2024cites this paper
• Contributions of Inflammation to Cardiometabolic Heart Failure with Preserved Ejection Fraction.

  2024cites this paper
• Myocardial inflammatory cells in cardiac amyloidosis

  2024cites this paper
• The associations of cytokines and gens polymorphisms of β-adrenoceptors in patients with heart failure and some thyroid pathology (literature review and own observations).

  2024cites this paper
• GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction

  2024cites this paper
• The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?

  2024cites this paper
• Rate Versus Rhythm Control for Atrial Fibrillation with Heart Failure.

  2024cites this paper
• Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

  2024cites this paper
• Macrophage-based therapeutic approaches for cardiovascular diseases

  2024cites this paper
• A new approach to characterize cardiac sodium storage by combining fluorescence photometry and magnetic resonance imaging in small animal research

  2024cites this paper
• Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae

  2024cites this paper
• Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction

  2024cites this paper
• Proteomic Profile of the ICAM1 p.K56M HFpEF Risk Variant

  2024cites this paper
• Pathophysiological insights into HFpEF from studies of human cardiac tissue

  2024cites this paper
• Research Progress on the Relationship between Hyperuricemia and Cardiovascular Disease

  2024cites this paper
• Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction

  2024cites this paper
• Smoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

  2024cites this paper
• Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

  2024cites this paper
• Computational investigation of the role of ventricular remodelling in HFpEF: The key to phenotype dissection

  2024cites this paper
• Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion

  2024cites this paper
• Comparison of diagnostic algorithms in clinically suspected viral myocarditis: Agreement between cardiovascular magnetic resonance, endomyocardial biopsy, and troponin T

  2024cites this paper
• Impact of Pre-Transplant Left Ventricular Diastolic Pressure on Primary Graft Dysfunction after Lung Transplantation: A Narrative Review

  2024cites this paper
• Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

  2024cites this paper
• Investigation of the efficacy of Dengzhan Shengmai capsule against heart failure with preserved ejection fraction.

  2024cites this paper
• Role of Trimethylamine N-Oxide in Heart Failure

  2024cites this paper
• Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives

  2024cites this paper
• Microvascular Dysfunction across the Spectrum of Heart Failure Pathology: Pathophysiology, Clinical Features and Therapeutic Implications

  2024cites this paper
• Coordinate Targeting of Mitochondrial Energetics, Antioxidant Defenses, and Inflammation

  2024cites this paper
• Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF

  2024cites this paper
• Exploring the therapeutic potential of tetrahydrobiopterin for heart failure with preserved ejection fraction: A path forward.

  2024cites this paper
• Interplay between Senescence and Macrophages in Diabetic Cardiomyopathy: A Review of the Potential Role of GDF-15 and Klotho

  2024cites this paper
• Relationship between heart failure and intestinal inflammation in infants with congenital heart disease

  2024cites this paper
• Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review

  2024cites this paper
• Comprehensive Analysis of Immune Cell Infiltration and M2-Like Macrophage Biomarker Expression Patterns in Atrial Fibrillation

  2024cites this paper
• HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients

  2024cites this paper
• Prevalence, Incidence, and Outcomes of Diastolic Dysfunction in Isolated Tricuspid Regurgitation: Perhaps Not Really "Isolated"?

  2024cites this paper
• Associations of Circulating Vascular Cell Adhesion Molecule‐1 and Intercellular Adhesion Molecule‐1 With Long‐Term Cardiac Function

  2024cites this paper
• M2 macrophage‐derived paracrine factor TNFSF13 affects the fibrogenic alterations in endothelial cells and cardiac fibroblasts by mediating the NF‐κB and Akt pathway

  2024cites this paper
• HBI‐8000 improves heart failure with preserved ejection fraction via the TGF‐β1/MAPK signalling pathway

  2024cites this paper
• Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• Heart Failure in Rheumatoid Arthritis: Clinical Implications

  2024cites this paper
• Menstruation-related symptoms are associated with physical activity and midpoint of sleep: a pilot study

  2023cites this paper
• The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies

  2023cites this paper
• Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights.

  2023cites this paper
• Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists

  2023cites this paper
• Fibroblasts and Immune Cells: At The Cross-Road of Organ Inflammation and Fibrosis.

  2023cites this paper
• Phosphodiesterase in heart and vessels: from physiology to diseases

  2023cites this paper
• Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases.

  2023cites this paper
• Pathogenesis of the Left Ventricular Diastolic Dysfunction: The Immune System Keeps Playing at the Backstage.

  2023cites this paper
• Epigenetics in Heart Failure: Role of DNA Methylation in Potential Pathways Leading to Heart Failure with Preserved Ejection Fraction

  2023cites this paper